NL8502010A - Nafthylanaloga van mevalonolacton en derivaten daarvan, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. - Google Patents

Nafthylanaloga van mevalonolacton en derivaten daarvan, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. Download PDF

Info

Publication number
NL8502010A
NL8502010A NL8502010A NL8502010A NL8502010A NL 8502010 A NL8502010 A NL 8502010A NL 8502010 A NL8502010 A NL 8502010A NL 8502010 A NL8502010 A NL 8502010A NL 8502010 A NL8502010 A NL 8502010A
Authority
NL
Netherlands
Prior art keywords
compound
formula
group
compounds
ester
Prior art date
Application number
NL8502010A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8502010A publication Critical patent/NL8502010A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C07C57/40—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic containing condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL8502010A 1984-07-24 1985-07-12 Nafthylanaloga van mevalonolacton en derivaten daarvan, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. NL8502010A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63380984A 1984-07-24 1984-07-24
US63380984 1984-07-24

Publications (1)

Publication Number Publication Date
NL8502010A true NL8502010A (nl) 1986-02-17

Family

ID=24541204

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8502010A NL8502010A (nl) 1984-07-24 1985-07-12 Nafthylanaloga van mevalonolacton en derivaten daarvan, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.

Country Status (21)

Country Link
JP (1) JPS6137754A (enrdf_load_stackoverflow)
KR (1) KR860001045A (enrdf_load_stackoverflow)
AU (1) AU4522685A (enrdf_load_stackoverflow)
BE (1) BE902914A (enrdf_load_stackoverflow)
DE (1) DE3525256A1 (enrdf_load_stackoverflow)
DK (1) DK333785A (enrdf_load_stackoverflow)
ES (1) ES8705356A1 (enrdf_load_stackoverflow)
FI (1) FI852851L (enrdf_load_stackoverflow)
FR (1) FR2568248A1 (enrdf_load_stackoverflow)
GB (1) GB2162179A (enrdf_load_stackoverflow)
GR (1) GR851805B (enrdf_load_stackoverflow)
HU (1) HUT39142A (enrdf_load_stackoverflow)
IL (1) IL75874A0 (enrdf_load_stackoverflow)
IT (1) IT1200095B (enrdf_load_stackoverflow)
LU (1) LU86012A1 (enrdf_load_stackoverflow)
NL (1) NL8502010A (enrdf_load_stackoverflow)
PH (1) PH21444A (enrdf_load_stackoverflow)
PL (1) PL254654A1 (enrdf_load_stackoverflow)
PT (1) PT80845B (enrdf_load_stackoverflow)
SE (1) SE8503556L (enrdf_load_stackoverflow)
ZA (1) ZA855594B (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904646A (en) * 1987-05-22 1990-02-27 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-COA reductase inhibitors
US5091378A (en) * 1987-05-22 1992-02-25 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
DE3722807A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
US4792614A (en) * 1987-08-05 1988-12-20 American Home Products Corporation Substituted furans as inhibitors of 3-hydroxy-3-methylglutaryl-coa reductase
US4812583A (en) * 1987-09-11 1989-03-14 American Home Products Corporation Substituted acyloxyalkylphenylethylene inhibitors of 3-hydroxy-3-methylglutaryl-coa reductase
DE3818570A1 (de) * 1988-06-01 1989-12-21 Boehringer Mannheim Gmbh Neue 6-substituierte-4-hydroxy-tetrahydro-pyran -2-on-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
CA2185961A1 (en) * 1996-09-19 1998-03-20 K.S. Keshava Murthy Process for producing simvastatin
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
KR100836960B1 (ko) 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55132595A (en) * 1979-04-04 1980-10-15 Nec Corp Semiconductor circuit

Also Published As

Publication number Publication date
PT80845B (en) 1987-03-24
ES545454A0 (es) 1987-05-01
PT80845A (en) 1985-08-01
LU86012A1 (fr) 1986-02-12
PH21444A (en) 1987-10-20
GR851805B (enrdf_load_stackoverflow) 1985-11-26
BE902914A (fr) 1986-01-17
AU4522685A (en) 1986-01-30
IL75874A0 (en) 1985-11-29
GB2162179A (en) 1986-01-29
JPS6137754A (ja) 1986-02-22
PL254654A1 (en) 1986-08-26
KR860001045A (ko) 1986-02-22
SE8503556L (sv) 1986-01-25
DE3525256A1 (de) 1986-01-30
DK333785D0 (da) 1985-07-22
IT8548385A0 (it) 1985-07-23
SE8503556D0 (sv) 1985-07-22
GB8518490D0 (en) 1985-08-29
HUT39142A (en) 1986-08-28
DK333785A (da) 1986-01-25
FI852851A7 (fi) 1986-01-25
IT1200095B (it) 1989-01-05
FI852851A0 (fi) 1985-07-22
ES8705356A1 (es) 1987-05-01
FI852851L (fi) 1986-01-25
FR2568248A1 (fr) 1986-01-31
ZA855594B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
KR900001212B1 (ko) 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도
AU628198B2 (en) (R-(R*R*))-2-(4-fluorohpenyl)-beta,delta-dihydroxy-5-(1- methylethyl-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1- heptanoic acid, its lactone form and salts thereof
IE893987L (en) Substituted 2-pyridones and pyrid-2-thiones, processes for¹their preparation and their use in medicaments
JP4524111B2 (ja) ＨＭＧ−ＣｏＡ還元酵素阻害剤の製造法
DK157543B (da) Pyrazolanaloge af mevalonolacton og derivater deraf samt deres anvendelse
US4866090A (en) Novel HMG-CoA reductase inhibitors
NL8502010A (nl) Nafthylanaloga van mevalonolacton en derivaten daarvan, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
WO1988001997A2 (en) Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals
US4308378A (en) Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones
JPH02731A (ja) 新規なＨＭＧ―ＣｏＡ還元酵素阻害剤
EP0024348B1 (en) Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-r trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them
US4829081A (en) Analogs of mevalonolactone and derivatives thereof
JPH02188571A (ja) 化合物
JPH021478A (ja) 二置換ピリジン類
US4645854A (en) Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit
JPH0196152A (ja) 新規なＨＭＧ−ＣｏＡ還元酵素阻害剤
JPH02745A (ja) 新規なＨＭＧ―ＣｏＡ還元酵素阻害剤
US4927851A (en) Analogs of mevalonolactone and derivatives thereof
HU209905B (en) Process for producing tetrazole derivatives and pharmaceutical compositions containing them
US5347039A (en) Process for the preparation of derivatives of 3,5-dihydroxypentanoic acid
US5095126A (en) Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids
IE892539L (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives¹thereof, a process for the preparation thereof, the use¹thereof as medicinal agents, pharmaceutical products and¹intermediates
EP0337885B1 (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP0283217A1 (en) Novel antihypercholesterolemic compounds
RU2058979C1 (ru) Производные алкенкарбоновой кислоты, или смеси их изомеров, или их индивидуальные изомеры, или соли, обладающие свойствами антагонистов лейкотриена, способы их получения, промежуточные для их получения, и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
BV The patent application has lapsed